$ANIP Balance Sheet | Understand Stock

$ANIP

$72.60 -$0.01 (0.01%) Close

$ANIP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current Assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventories
Assets held for sale
Prepaid income taxes
Prepaid expenses and other current assets
Investment in equity securities
Total Current Assets
Property and equipment
Accumulated depreciation
Non-current Assets
Property and equipment, net
Non-Current restricted cash
Deferred tax assets, net
Intangible assets, net
Goodwill
Other non-current assets

Total Assets
Liabilities and Stockholders’ Equity
Current Liabilities
Accounts payable
Accrued royalties
Accrued compensation and related expenses
Current income taxes payable, net
Accrued government rebates
Returned goods reserve
Deferred revenue
Current contingent consideration
Accrued licensor payment
Accrued expenses and other
Income taxes payable
Income taxes payable - foreign
Current debt, net
Total Current Liabilities

Non-current Liabilities
Debt, net
Convertible notes, net
Accrued licensor payments due
Contingent consideration
Other non-current liabilities
Total Liabilities
Convertible Preferred Stock, Series A, $0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at December 31, 2025 and 25,000 shares issued and outstanding at December 31, 2024
Stockholders’ Equity
Common Stock, $0.0001 par value, 66,000,000 shares authorized; 23,853,338 shares issued and 22,961,423 shares outstanding at June 30, 2026; 23,112,577 shares issued and 22,491,281 shares outstanding at December 31, 2025
Class C Special Stock, $0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Preferred Stock, $0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Treasury stock, 891,915 shares of common stock, at cost, at June 30, 2026 and 621,296 shares of common stock, at cost, at December 31, 2025
Additional paid-in capital
Retained earnings (Accumulated deficit)
Accumulated other comprehensive (loss) income, net of tax
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity
Common Stock, shares authorized (in shares)

Comments